Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
3.020
-0.147 (-4.64%)
At close: Dec 5, 2025, 4:00 PM EST
3.010
-0.010 (-0.33%)
After-hours: Dec 5, 2025, 6:25 PM EST

Silexion Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2013 FY 2012
Period Ending
Sep '25 Dec '24 Dec '23 Dec '13 Dec '12
Net Income
-9.25-16.44-4.94-1.36-0.94
Depreciation & Amortization
-00.030.0500
Loss (Gain) From Sale of Assets
0.020.02-0--
Stock-Based Compensation
0.15.860.130.420.04
Other Operating Activities
0.063.720.15--
Change in Accounts Receivable
---0.06-0.1
Change in Accounts Payable
0.150.610.080.020.06
Change in Other Net Operating Assets
-1.8-2.190.010.050.03
Operating Cash Flow
-10.73-8.4-4.53-0.79-0.91
Capital Expenditures
-0.01-0.02-0.01-0.01-0
Sale of Property, Plant & Equipment
--0.08--
Investment in Securities
--0.51--
Other Investing Activities
----0.01-0.03
Investing Cash Flow
-0.01-0.020.57-0.02-0.03
Long-Term Debt Repaid
--0.25---
Net Debt Issued (Repaid)
-0.95-0.25---
Issuance of Common Stock
21.113.05--1.72
Other Financing Activities
-2.122.3---
Financing Cash Flow
18.055.10.52-1.72
Foreign Exchange Rate Adjustments
-0.11-0.06-0.23--
Net Cash Flow
7.2-3.38-3.66-0.810.78
Free Cash Flow
-10.74-8.42-4.54-0.8-0.91
Free Cash Flow Per Share
-18.84-202.40---
Cash Interest Paid
0.040.03---
Levered Free Cash Flow
-7.11-2.41--0.31-
Unlevered Free Cash Flow
-7.1-2.39--0.3-
Change in Working Capital
-1.65-1.580.090.13-0.02
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q